ID   ULA
AC   CVCL_1854
SY   Uppsala Lymphoma Ascites-fluid
DR   BioSample; SAMN03473508
DR   ChEMBL-Cells; CHEMBL4523525
DR   ChEMBL-Targets; CHEMBL4523556
DR   DSMZ; ACC-627
DR   DSMZCellDive; ACC-627
DR   GEO; GSM1374977
DR   PubChem_Cell_line; CVCL_1854
DR   Wikidata; Q54990721
RX   PubMed=17487752;
RX   PubMed=26727417;
CC   Doubling time: ~40-60 hours (DSMZ=ACC-627).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-627
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 14,16
ST   D21S11: 30,31
ST   D2S1338: 23,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 19,21
ST   Penta D: 9,12
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
RX   PubMed=17487752; DOI=10.1080/10428190701230866;
RA   Berglund M., Thunberg U., Fridberg M., Wingren A.G., Gullbo J.,
RA   Leuchowius K.-J., Amini R.-M., Lagercrantz S., Horvat A., Enblad G.,
RA   Soderberg O.;
RT   "Establishment of a cell line from a chemotherapy resistant diffuse
RT   large B-cell lymphoma.";
RL   Leuk. Lymphoma 48:1038-1041(2007).
//
RX   PubMed=26727417; DOI=10.3109/10428194.2015.1108414;
RA   Drexler H.G., Eberth S., Nagel S., MacLeod R.A.F.;
RT   "Malignant hematopoietic cell lines: in vitro models for double-hit
RT   B-cell lymphomas.";
RL   Leuk. Lymphoma 57:1015-1020(2016).
//